Inventor
MARTA NEVALAINEN
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations42%
C07DHeterocyclic compounds42%
A61KPreparations for medical, dental or toiletry purposes8%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%
PatentTitleYear
12,570,631Substituted N-(4-(pyrimidin and pyridin-4-yl)benzylcarboxamides and its use for treating disorders responsive to inhibition of Btk202612,565,500Substituted pyrrolo[1,2-b]pyridazines and pyrrolo[2,1-f][1,2,4]triazines as Btk inhibitors202612,391,697Condensed bi-heterocycles as inhibiting agents for Bruton's tyrosine kinase202512,240,838Inhibiting agents for Bruton's tyrosine kinase202511,926,619Certain pladienolide compounds and methods of use2024Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2024Patents assigned to EISAI R&D MAN CO LTD (1)· patent assignee history
2024–2026Based in US· patent location history
2025–2026Patents assigned to BIOGEN MA INC (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BIOGEN MA INC | 4 | 2025–2026 |
| EISAI R&D MAN CO LTD | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2024–2026 |